BRAIN+ SHOWCASED AT DANISH DEMENTIA DAYS & ALTENPFLEGE IN GERMANY - Brain+ was selected as one of the most promising new elderly care technology start-ups at the annual German elderly care conference, Altenpflege https://t.co/LUwG02z1K7

The Dementia Days 2023 conference in Copenhagen is concluded with over 1000 participants. Thank you to all who stopped by our booth for a talk about CST and how we can support your work with the CST-Assistant.

BRAIN+ CLOSES ITS SECOND SALES CONTRACT FOR CST - Therapist Companion with a dementia care center in Gladsaxe municipality https://t.co/MGlZgJ03zx

Learn more about the current Brain+ unit rights issue: Topics discussed: - Turbulent market conditions - Existing shareholders - What you get in the rights issue - Use of funds - The business case of Brain+ https://t.co/7XK8F8kJvQ

MALTESER HILFSDIENST AND BRAIN+ BEGIN COLLABORATION to offer people with dementia access to CST in special dementia cafes in Germany The first step is a 2-months pilot offering of Brain+’ German version of CST-Therapist Companion https://t.co/j8N49PH0PB

Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market. Read more: https://t.co/zjfNJebUaO #alzheimers #dementia #DTx #digitaltherapeutics #digitalmedicine #brainhealth #mentalhealth

A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results in significantly larger benefits over and above that of medication alone. Read more: https://t.co/y1PRFFbmCG #alzheimers

BRAIN+ EXPANDS ITS FIRST SALES CONTRACT, close to doubling it This is important because it shows the potential for growing engagements with customers after an initial contract has been established https://t.co/zmMuYepNc7

RESPECTED DEMENTIA EXPERTS AND BRAIN+ GET EU GRANT TO RESEARCH how to optimize digital at-home treatments for people with dementia - The grant (€48,405) covers research into the two main therapeutic technologies of Brain+, digitalized CST, and CCT. https://t.co/5sgDr5KSUC

NEW COCHRANE REVIEW CONFIRMS CST Provides further solid support for the increased adoption of CST as a non-pharmaceutical dementia therapy worldwide and for Brain+’ CST-based suite of digital dementia products. https://t.co/Rp6BfmZUsf

Important opportunity for Brain+ to present its innovative digital solutions for better care and treatment of Alzheimer’s and other types of dementia to key Japanese industry and academic stakeholders. Read more: https://t.co/ycFwMluGto #alzheimers #dementia #DTx

The ‘Alzheimer’s Detect & Prevent’ project, led by Brain+ and funded under the EU Horizon2020 innovation framework, has been approved by the European Commission. Read more: https://t.co/f0ZG0a73Qr #alzheimers #dementia #DTx #digitaltherapeutics #digitalmedicine #brainhealth

Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration https://t.co/y0X4NLuGIo

Promising feasibility indications for Brain+’ CCT technology for cognitive training Indications of clinical feasibility of the CCT technology & Starry Night cognitive test, provide early support for the pipeline product for Mild Cognitive Impairment. https://t.co/XCMbIm1fyI

Brain+ first municipal sale of its new dementia product - The sale covers the use of the ‘basic package’ of the CST-Therapist Companion in one training facility for one year, in the municipality of Herning, at an introductory price of 50.000 DKK. https://t.co/MZnBiczeG9

3-Year Innovation Project is Completed with the Brain+ CST-Therapist Companion product as the final output The 3-year ‘CIRCULAR Co-Creation’ project has been the backbone of the development of all the Brain+ CST products. https://t.co/ATfS9CGrxh

Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcements. https://t.co/b5S7NKsvb1

Pilot with volunteers from DaneAge Association Brain+ is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) to test the use of CST-Therapist Companion to enable volunteers to deliver CST to the members of the association. https://t.co/khVyAvWR9A

Implementation of an ISO 13485 for Medical Devices Having a standardized QMS in place is key requirement for development & commercialization of compliant digital therapeutics. Supports the company’s objective to attract large pharma partnerships. https://t.co/eGcc0A3GYX

WHO endorses CST and digital solutions of dementia therapy - Brain+ is at the forefront of digital therapeutics and the first to have developed a digital version of CST for its upscaled and wider use and adoption https://t.co/T8tqaPQ6zs